177 related articles for article (PubMed ID: 12140139)
1. Immunologic parameters as significant prognostic factors in lung cancer.
Nakamura H; Saji H; Ogata A; Hosaka M; Hagiwara M; Kawasaki N; Konaka C; Kato H
Lung Cancer; 2002 Aug; 37(2):161-9. PubMed ID: 12140139
[TBL] [Abstract][Full Text] [Related]
2. Cellular immunologic parameters related to age, gender, and stage in lung cancer patients.
Nakamura H; Kawasaki N; Hagiwara M; Saito M; Konaka C; Kato H
Lung Cancer; 2000 May; 28(2):139-45. PubMed ID: 10717331
[TBL] [Abstract][Full Text] [Related]
3. Peripheral leukocytes with HLA-DR+/CD8- phenotype are associated with prognosis in patients with lung cancer.
Nakamura H; Saji H; Aute I; Kawasaki N; Hosaka M; Ogata A; Saijo T; Kato H
Anticancer Res; 2003; 23(5b):4149-52. PubMed ID: 14666616
[TBL] [Abstract][Full Text] [Related]
4. Thoracotomy is associated with significantly more profound suppression in lymphocytes and natural killer cells than video-assisted thoracic surgery following major lung resections for cancer.
Ng CS; Lee TW; Wan S; Wan IY; Sihoe AD; Arifi AA; Yim AP
J Invest Surg; 2005; 18(2):81-8. PubMed ID: 16036776
[TBL] [Abstract][Full Text] [Related]
5. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE
Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827
[TBL] [Abstract][Full Text] [Related]
6. Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.
O'Callaghan DS; Rexhepaj E; Gately K; Coate L; Delaney D; O'Donnell DM; Kay E; O'Connell F; Gallagher WM; O'Byrne KJ
Eur Respir J; 2015 Dec; 46(6):1762-72. PubMed ID: 26541534
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer.
Laudanski J; Burzykowski T; Niklinska W; Chyczewski K; Furman M; Niklinski J
Lung Cancer; 1998 Dec; 22(3):191-200. PubMed ID: 10048472
[TBL] [Abstract][Full Text] [Related]
8. An increase in the percentage of HLA-DR-positive peripheral leukocytes predicts a poor prognosis in patients with squamous cell carcinoma of the lung.
Nakamura H; Idiris A; Kato Y; Kato H
Oncol Rep; 2004 Mar; 11(3):673-6. PubMed ID: 14767520
[TBL] [Abstract][Full Text] [Related]
9. [Immunomorphology of lymph nodes and prognosis in lung cancer].
Di Giorgio A; Sammartino P; Canavese A; Arnone P; Sibio S; Accarpio F; Al Mansour M
Minerva Chir; 2001 Apr; 56(2):153-9. PubMed ID: 11353348
[TBL] [Abstract][Full Text] [Related]
10. Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer.
Augustin F; Fiegl M; Schmid T; Pomme G; Sterlacci W; Tzankov A
J Clin Pathol; 2015 May; 68(5):368-73. PubMed ID: 25731190
[TBL] [Abstract][Full Text] [Related]
11. Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung.
Fujisawa T; Yamaguchi Y
Cancer; 1997 Feb; 79(3):474-81. PubMed ID: 9028357
[TBL] [Abstract][Full Text] [Related]
12. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
13. Assessment of local cellular immunity in lung cancer by bronchoalveolar lavage.
Lorenz J; Müller-Quernheim J; Castillo-Höfer C; Doboszỳnska A; Ferlinz R
Klin Wochenschr; 1990 Jul; 68(14):728-34. PubMed ID: 1975283
[TBL] [Abstract][Full Text] [Related]
14. Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach.
Paulsen EE; Kilvaer TK; Khanehkenari MR; Al-Saad S; Hald SM; Andersen S; Richardsen E; Ness N; Busund LT; Bremnes RM; Donnem T
Clin Lung Cancer; 2017 Mar; 18(2):220-233.e8. PubMed ID: 27816392
[TBL] [Abstract][Full Text] [Related]
15. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma.
Talebian Yazdi M; van Riet S; van Schadewijk A; Fiocco M; van Hall T; Taube C; Hiemstra PS; van der Burg SH
Oncotarget; 2016 Jan; 7(3):3477-88. PubMed ID: 26658106
[TBL] [Abstract][Full Text] [Related]
16. MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cells.
Srivastava MK; Bosch JJ; Wilson AL; Edelman MJ; Ostrand-Rosenberg S
Int J Cancer; 2010 Dec; 127(11):2612-21. PubMed ID: 20473949
[TBL] [Abstract][Full Text] [Related]
17. Impact of Lymphocyte Subsets on Chemotherapy Efficacy and Long-term Survival of Patients with Advanced Non-small-cell Lung Cancer.
Wei Z; Zhang W; Gao F; Wu Y; Zhang G; Liu Z; Jiao S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Jun; 39(3):371-376. PubMed ID: 28695808
[TBL] [Abstract][Full Text] [Related]
18. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
[TBL] [Abstract][Full Text] [Related]
19. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S
Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
